Xcout Intel
GlycoEra competitors & alternatives
The 12 closest competitors and alternatives to GlycoEra among biotechnology companies — ranked by similarity to what GlycoEra actually does, not by market-cap band.
Subscribe to see GlycoEra’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About GlycoEra
GlycoEra AG is a biotechnology company focused on advancing glycan-mediated therapy through game-changing protein engineering. Headquartered in Wädenswil, Switzerland, the company also maintains an office in Newton, Massachusetts.
GlycoEra at a glance
GlycoEra is a biotechnology company headquartered in Switzerland. Xcout tracks 14 named people at GlycoEra, including Ganesh V. Kaundinya, PhD (President & CEO).
GlycoEra leadership
- Ganesh V. Kaundinya, PhDPresident & CEO
- Andrea MatthewsChief Business Officer
- Petra Duda, M.D., Ph.D.Chief Medical Officer
- Tanmoy C. Ganguly, PhDChief Scientific Officer
- Georges GemayelChairperson
- Colleen GrahamSVP, Head of Clinical Operations
8 more named people on record for GlycoEra, with roles, board committees and tenure — see the full roster →
Top 12 GlycoEra competitors
Ranked by semantic similarity — how close each company is to GlycoEra by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
Nabla Bio is a biotechnology company headquartered in Cambridge, Massachusetts. It develops protein engineering platforms and technical solutions.
Similar biotechnology company
Mythic Therapeutics, Inc. is a biotechnology research company headquartered in Waltham, Massachusetts. The company is dedicated to developing a proprietary platform to enhance the effectiveness of antibody-drug conjugates and other antibody-based therapeutics.
Similar biotechnology company
GlycoMimetics, Inc. is a U.S. biotechnology company that develops glycomimetic drugs designed to modulate carbohydrate-mediated biological interactions. Its programs have focused on therapeutics for diseases including cancer and inflammatory disorders, serving patients through partnerships and clinical development rather than as a direct consumer business.
Biotech
Maxion Therapeutics is a biotechnology company headquartered in Cambridge, England, utilizing proprietary KnotBody technology to discover and develop first-in-class protein therapeutics.
Biotech
Expedition Medicines, Inc. is a biotechnology company founded in 2022 and headquartered in Cambridge, Massachusetts, focused on generatively designing novel drugs targeting specific proteins.
Similar biotechnology company
Alloy Therapeutics, Inc. is a biotechnology ecosystem company dedicated to democratizing access to antibodies, multispecifics, and genetic modalities, with offices in Waltham and Boston, Massachusetts.
Similar biotechnology company
Catena Biosciences is a biotechnology company based in Berkeley, California, that pioneers protein conjugation technologies for novel therapeutics. Founded in 2020, the company builds upon technology developed in labs at the University of California, Berkeley.
Similar biotechnology company
KiraGen Bio is a Boston-based biotechnology company pioneering the development of AI-driven, multiplex gene-edited CAR-T cell therapies designed to target and block tumor suppression.
Biotech
DynamiCure Biotechnology is a life sciences company applying innovative approaches to drug discovery from its facilities in Waltham, Massachusetts.
Biotech
Photys Therapeutics, Inc. is a proximity-based biotechnology holding company founded in 2021 and headquartered in Massachusetts, United States. The company focuses on discovering and developing novel targeted protein therapeutics.
Similar biotechnology company
Outpace Bio, Inc. is a biotechnology company headquartered in Seattle, Washington, specializing in AI-powered protein design to advance cell therapies.
Similar biotechnology company
Endogena Therapeutics, Inc. is a clinical-stage biotechnology company headquartered in Zürich, Switzerland, that discovers and develops first-in-class endogenous regenerative medicines to repair tissues.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of GlycoEra and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for GlycoEraand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →